Relation of Frailty to Outcomes After Transcatheter Aortic Valve Replacement (from the PARTNER Trial)

Transcatheter aortic valve replacement (TAVR) is an effective treatment for severe symptomatic aortic stenosis (AS) in patients who are inoperable or at high risk for surgery. However, the intermediate to long-term mortality is high, emphasizing the importance of patient selection. We therefore soug...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Am J Cardiol
Autores principales: Green, Philip, Arnold, Suzanne V, Cohen, David J, Kirtane, Ajay J., Kodali, Susheel, Brown, David L., Rihal, Charanjit S., Xu, Ke, Lei, Yang, Hawkey, Marian C., Kim, Rebeca J., Alu, Maria, Leon, Martin B, Mack, Michael J
Formato: Artigo
Lenguaje:Inglês
Publicado: 2015
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4475494/
https://ncbi.nlm.nih.gov/pubmed/25963221
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.amjcard.2015.03.061
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares